2023-509765-20-00
CTIS ↗
FYB206-C1-01
Melanoma: Adjuvant treatment of patients with Stage IIB, IIC, or III melanoma following complete resection
pharma · NSCLC
Formycon
Formycon AG
Formycon trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Planegg, DE HQ
2012 Founded
178 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Planegg, DE
- Founded
- 2012
- Employees
- 178
- Programs
- 2
- Drugs
- 4
- Patents
- 0
Formycon clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to Formycon programs — each row shows trial ID, program name, phase, status, and indication.
Formycon trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Formycon.